 |
 |

Prognostic Significance of Oral Lesions in Children With Perinatally Acquired Human Immunodeficiency Virus Infection
Mitchell H. Katz, MD;
Mary T. Mastrucci, MD;
Penelope J. Leggott, BDS;
Janice Westenhouse, MPH;
John S. Greenspan, BDS, PhD, FRCPath;
Gwendolyn B. Scott, MD
Am J Dis Child. 1993;147(1):45-48.
Abstract
Objective. —To assess the prevalence and prognostic significance of oral lesions in children with human immunodeficiency virus infection.
Design. —Clinical cohort study.
Setting. —Children's Hospital Center at Jackson Memorial Hospital, Miami, Fla.
Participants. —Ninety-nine children with perinatally acquired human immunodeficiency virus infection examined longitudinally for oral lesions.
Interventions. —None.
Measurements/Main Results. —Presence of oral lesions was determined by a pediatrician who had been trained in the diagnosis of oral lesions. The cumulative prevalence of lesions was 72% for oral candidiasis, 47% for parotid enlargement, and 24% for herpes simplex. The median time from birth to development of a lesion was 2.4 years for candidiasis, 4.6 years for parotid enlargement, and 5 years for herpes simplex. The median time from lesion to death was 3.4 years for patients with candidiasis, 5.4 years for patients with parotid enlargement, and 4.3 years for patients with herpes simplex. In a time-dependent proportional-hazards model, oral candidiasis was associated with a more rapid rate of progression to death (relative hazard, 14.2; 95% confidence interval, 4.8 to 41.8), while parotid enlargement was associated with a less rapid rate of progression to death (relative hazard, 0.38; 95% confidence interval, 0.16 to 0.88) and herpes simplex was unrelated to the rate of progression (relative hazard, 1.3; 95% confidence interval, 0.5 to 3.1).
Conclusions. —The presence of oral candidiasis and parotid enlargement confer important prognostic information and should be incorporated into decisions regarding therapy for HIV-infected children.
AJDC. 1993;147:45-48)
Author Affiliations
From the Oral AIDS Center, Department of Stomatology, University of California, San Francisco (Drs Katz and Greenspan and Ms Westenhouse); Department of Public Health, San Francisco, Calif (Dr Katz); Department of Pediatrics, University of Miami, Fla (Drs Mastrucci and Scott); and Department of Clinical Dental Sciences, University of British Columbia, Vancouver, Canada (Dr Leggott).
Footnotes
Accepted for publication August 18, 1992.
Reprints not available.
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Viruses and Salivary Gland Disease (SGD): Lessons from HIV SGD
Jeffers and Webster-Cyriaque
ADR 2011;23:79-83.
ABSTRACT
| FULL TEXT
(A1) Identification of Oral Health Care Needs in Children and Adults, Management of Oral Diseases
Hodgson et al.
ADR 2006;19:106-117.
ABSTRACT
| FULL TEXT
The significance of oral health in HIV disease
Chapple and Hamburger
Sex. Transm. Infect. 2000;76:236-243.
FULL TEXT
Possible Malignant Transformation of Benign Lymphoepithelial Parotid Lesions in Human Immunodeficiency Virus-Infected Patients: Report of Three Cases
Del Bono et al.
Clinical Infectious Diseases 2000;30:947-949.
ABSTRACT
| FULL TEXT
|